SFCM
ALXO icon

Seven Fleet Capital Management’s ALX Oncology ALXO Stock Holding History

Seven Fleet Capital Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-117,817
Closed -$133K – 117
2025
Q4 		$133K Buy
+117,817
New +$178K 0.09% 70

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Seven Fleet Capital Management's ALXO Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of ALX Oncology (ALXO) in Q1 2026, closing a stake of 117,817 shares — an estimated $133K sold.

Seven Fleet Capital Management first reported a position in ALXO in Q4 2025 and held it in 1 quarter. The position peaked at $133K in Q4 2025. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Seven Fleet Capital Management reported no remaining ALX Oncology position as of Q1 2026 after selling out during the quarter.
  • Seven Fleet Capital Management sold 117,817 ALX Oncology shares in Q1 2026, an estimated $133K.
  • Seven Fleet Capital Management first reported a position in ALX Oncology in Q4 2025 and held it in 1 quarter.
  • Seven Fleet Capital Management's ALX Oncology position peaked at $133K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.